Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0030-1265174 ◽

2010 ◽

Vol 119 (02) ◽

pp. 63-68 ◽

Cited By ~ 18

Author(s):

N. P. E. Kadoglou ◽

A. Kapelouzou ◽

H. Tsanikidis ◽

I. Vitta ◽

C. Liapis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Metformin Monotherapy ◽

Dose Combination ◽

Drug Naïve

Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

Value in Health ◽

10.1016/j.jval.2016.09.1844 ◽

2016 ◽

Vol 19 (7) ◽

pp. A667

Author(s):

I Daacke ◽

S Kanters ◽

K Thorlund ◽

A Tebboth

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Relative Efficacy ◽

Efficacy And Safety ◽

Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial

10.1111/dom.13496 ◽

2018 ◽

Vol 21 (1) ◽

pp. 136-145 ◽

Cited By ~ 5

Author(s):

Kohei Kaku ◽

Masakazu Haneda ◽

Yuko Tanaka ◽

Ganghyuck Lee ◽

Kosuke Shiki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Safety Profile ◽

Controlled Trial ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial

10.1111/dom.13491 ◽

2018 ◽

Vol 21 (1) ◽

pp. 103-111 ◽

Cited By ~ 1

Author(s):

Ji Cheol Bae ◽

Kyung Wan Min ◽

Yong Hyun Kim ◽

Kyoung-Ah Kim ◽

Eun-Gyoung Hong ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial

10.1111/dom.13352 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2200-2209 ◽

Cited By ~ 15

Author(s):

Ryuzo Kawamori ◽

Masakazu Haneda ◽

Keiko Suzaki ◽

Gang Cheng ◽

Kosuke Shiki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Safety Profile ◽

Controlled Trial ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial

10.1111/dom.12875 ◽

2017 ◽

Vol 19 (5) ◽

pp. 754-758 ◽

Cited By ~ 10

Author(s):

Linong Ji ◽

Ling Li ◽

Jian Kuang ◽

Tao Yang ◽

Dong-Jun Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Phase 3 ◽

Asian Patients ◽

Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study

Journal of Diabetes ◽

10.1111/1753-0407.12432 ◽

2016 ◽

Vol 9 (4) ◽

pp. 412-422 ◽

Cited By ~ 6

Author(s):

Sang Soo Kim ◽

In Joo Kim ◽

Kwang Jae Lee ◽

Jeong Hyun Park ◽

Young Il Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

BLOOD PRESSURE LOWERING RESPONSE WITH THE FIXED DOSE COMBINATION PERINDOPRIL/INDAPAMIDE IN THAI PATIENTS WITH TYPE 2 DIABETES AND ADDED RISK FACTORS: PP.5.190

Journal of Hypertension ◽

10.1097/01.hjh.0000378514.03077.46 ◽

2010 ◽

Vol 28 ◽

pp. e105

Author(s):

V Ophascharoensuk ◽

K Phimda

Keyword(s):

Risk Factors ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Blood Pressure Lowering ◽

Pressure Lowering ◽